Literature DB >> 3048369

Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study.

K Kragballe1, H I Beck, H Søgaard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3048369     DOI: 10.1111/j.1365-2133.1988.tb03204.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  17 in total

1.  Studies on psoriatic osteopathy.

Authors:  G Hein; K Abendroth; A Müller; G Wessel
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

2.  Side to side comparison of topical treatment in atopic dermatitis.

Authors:  P F Ainley-Walker; L Patel; T J David
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

3.  Vitamin D analogs in the treatment of psoriasis: Where are we standing and where will we be going?

Authors:  Léa Trémezaygues; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2011-07-01

Review 4.  Extraskeletal actions of vitamin D.

Authors:  Daniel D Bikle
Journal:  Ann N Y Acad Sci       Date:  2016-07       Impact factor: 5.691

5.  Effect of 1,25-dihydroxyvitamin D3 on human keratinocytes grown under different culture conditions.

Authors:  J A McLane; M Katz; N Abdelkader
Journal:  In Vitro Cell Dev Biol       Date:  1990-04

Review 6.  Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook.

Authors:  Jörg Reichrath; Christos C Zouboulis; Thomas Vogt; Michael F Holick
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

7.  Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line.

Authors:  M G Thomas; S Tebbutt; R C Williamson
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

Review 8.  Vitamin D3 and skin diseases.

Authors:  K Kragballe
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

Review 9.  Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris.

Authors:  D Murdoch; S P Clissold
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

10.  Calcipotriol inhibits rectal epithelial cell proliferation in ulcerative proctocolitis.

Authors:  M G Thomas; K P Nugent; A Forbes; R C Williamson
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.